EblacZ tumor dormancy in bone marrow and lymph nodes: Active control of proliferating tumor cells by CD8+ immune T cells

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5439-5446

  Müller, Markus ^a   Gounari, Fotini ^a   Prifti, Sophia ^a   Hacker, Hans Jörg ^a   Schirrmacher, Volker ^a   Khazaie, Khashayarsha ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; KI 67 ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER GROWTH; CANCER IMMUNOLOGY; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; IMMUNITY, CELLULAR; IMMUNIZATION, PASSIVE; LAC OPERON; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOMA; MICE; MICE, INBRED DBA; MICE, SCID; NEOPLASM METASTASIS; S PHASE; TUMOR MARKERS, BIOLOGICAL; VACCINATION;

EID: 0032401860     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Schirrmacher, V., Bosslet, K., Shantz, G., Clauer, K., and Hübsch, D. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Int. J. Cancer, 23: 245-252, 1979.
2. Schirrmacher, V., Shantz, G., Clauer, K., Komitowski, D., and Zimmermann, H. P. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastases formation in vivo. Int. J. Cancer, 23: 233-244, 1979.
3. Schirrmacher, V., and Bosslet, K. Tumor metastases and cell mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity. Int. J. Cancer, 25: 781-788, 1980.
4. Schirrmacher, V., Fogel, M., Russmann, E., Bosslet, K., Altevogt, P., and Beck, L. Antigenic variation in cancer metastasis: immune escape versus immune control. Cancer Metastasis Rev., 1: 241-274, 1982.
5. Schirrmacher, V., Leidig, S., and Griesbach, A. In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity. Cancer Immunol. Immunother., 33: 299-306, 1991.
6. Weinhold, K. J. L. T., Goldstein, L. T., and Wheelock, E. F. Tumour-dormant state established with L5178 lymphoma cells in immunized syngeneic murine hosts. Nature (Lond.), 270: 59-60, 1977.
7. Weinhold, K. J., Goldstein, L. T., and Wheelock, E. F. The tumor dormant state: quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice. J. Exp. Med., 149: 732-744, 1979.
8. Weinhold, K. J., Miller, D. A., and Wheelock, E. F. The tumor dormant state: comparison of L5178Y cells used to establish dormancy with those that emerge after its termination. J. Exp. Med., 149: 745-757, 1979.
9. Chen, L. P., Suzuki, Y., Liu, C. M., and Wheelock, E. F. Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: dependence of interleukin 2 on induced interferon-γ and on tumor necrosis factor for its antitumor effects. Cancer Res., 50: 1368-1374, 1990.
10. Wheelock, E. F., Yang, G., and Chen, L. Immune regulation of a murine T-cell lymphoma dormant state. In: T. H. M. Stewart and E. F. Wheelock (eds.), Cellular Immune Mechanisms and Tumor Dormancy, pp. 53-65. Boca Raton, FL: CRC Press, 1992.
11. Khazaie, K., Prifti, S., Beckhove, P., Griesbach, A., Russell, S., Collins, M., and Schirrmacher, V. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc. Natl. Acad. Sci. USA, 91: 7430-7434, 1994.
12. Wheelock, E. F. An overview of mechanisms responsible for tumor dormancy. In: T. H. M. Stewart and E. F. Wheelock (eds.), Cellular Immune Mechanisms and Tumor Dormancy, pp. 1-17. Boca Raton, FL: CRC Press, 1992.
13. Danos, O., and Heard, J. M. Retroviral mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA, 88: 8377-8381, 1991.
14. Danos, O., and Mulligan, R. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host range. Proc. Natl. Acad. Sci. USA, 85: 6460-6464, 1988.
15. Kubo, R. T., Born, W., Kappler, J. W., Marrack, P., and Pigeon, M. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol., 142: 2736-2742, 1989.
16. Schild, H-J., Kyewski, B., Von Hoegen, P., and Schirrmacher, V. CD4+ helper T cells are required for resistance to a highly metastatic murine tumor. Eur. J. Immunol., 17: 1863-1866, 1987.
17. Schirrmacher, V., and Zangemeister-Wittke, U. Gamma-irradiation suppresses T cell mediated protective immunity against a metastatic tumor in the afferent phase of the immune response but enhances it in the efferent phase if given before immune cell transfer. Int. J. Oncol., 4: 335-346, 1994.
18. Schirrmacher, V., Beckhove, P., Krüger, A., Rocha, M., Umansky, V., Fichtner, K. P., Hull, W. E., Zangemeister-Wittke, U., Griesbach, A., Jurianz, K., and von-Hogen, P. Effective immune rejection of advanced metastasized cancer. Int. J. Oncol., 6: 505-521, 1995.
19. Morecki, S., Pugatsch, T., Levi, S., Moshel, Y., and Slavin, S. Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL-1). Int. J. Cancer, 65: 204-208, 1996.
20. Eccles, S. Dormancy in experimental solid tumor systems. In: T. Stewart and F. Wheelock (eds.), Cellular Immune Mechanisms and Tumor Dormancy, pp. 27-53. Boca Raton, FL: CRC Press, 1993.
21. Dolberg, D. S., Hollingsworth, R., Hertle, M., and Bissell, M. J. Wounding and its role in RSV-mediated tumor formation. Science (Washington DC), 230: 676-678, 1985.
22. Sieweke, M. H., Thompson, N. L., Sporn, M. B., and Bissell, M. J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science (Washington DC), 248: 1656-1660, 1990.
23. Martins, G. M., Boudreau, N., and Bissell, M. J. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res., 54: 4334-4341, 1994.
24. Wisner, T. W., England, J. M., Pan, D. Y., Stoker, A. W., and Halpern, M. S. Tumor immunity generated in the course of regression of v-src-induced sarcomas. J. Virol., 65: 7020-7024, 1991.
25. Pantel, K., Izbicki, J., Passlick, B., Angstwurm, M., Haussinger, K., Thetter, O., and Riethmuller, G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet, 347: 649-653, 1996.
26. Pantel, K., Aignherr, C., Kollermann, J., Caprano, J., Riethmuller, G., and Kollermann, M. W. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer. Eur. J. Cancer, 31A: 1627-1632, 1995.
27. Riesenberg, R., Oberneder, R., Kriegmair, M., Epp, M., Bitzer, U., Hofstetter, A., Braun, S., Riethmuller, G., and Pantel, K. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. Histochemistry, 99: 61-66, 1993.
28. Braun, S., and Pantel, K. Immunodiagnosis and immunotherapy of isolated tumor cells disseminated to bone marrow of patients with colorectal cancer. Tumori, 81: 78-83, 1995.
29. Schlimok, G., Funke, I., Bock, B., Schweiberer, B., Witte, J., and Riethmuller, G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J. Clin. Oncol., 8: 831-837, 1990.
30. Gath, H. J., Heissler, E., Hell, B., Bier, J., Riethmuller, G., and Pantel, K. Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int. J. Oral Maxillofac. Surg., 24: 351-355, 1995.
31. Jauch, K. W., Heiss, M. M., Gruetzner, U., Funke, I., Pantel, K., Babic, R., Eissner, H. J., Riethmuller, G., and Schildberg, F. W. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J. Clin. Oncol., 14: 1810-1817, 1996,
32. Schlimok, G., Funke, I., Pantel, K., Strobel, F., Lindemann, F., Witte, J., and Riethmuller, G. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur. J. Cancer, 27: 1461-1465, 1991.
33. Pantel, K., Schlimok, G., Braun, S., Kutter, D., Lindemann, F., Schaller, G., Funke, I., Izbicki, J. R., and Riethmuller, G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst., 85: 1419-1424, 1993.
34. Funke, I., Fries, S., Rolle, M., Heiss, M. M., Untch, M., Bohmert, H., Schildberg, F. W., and Jauch, K. W. Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int. J. Cancer, 65: 755-761, 1996.
35. Passlick, B., Izbicki, J. R., Kubuschok, B., Nathrath, W., Thetter, O., Pichlmeier, U., Schweiberer, L., Riethmuller, G., and Pantel, K. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J. Clin. Oncol., 12: 1827-1832, 1994.
36. Schirrmacher, V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res., 43: 1-73, 1985.
37. Kohn, E. C., and Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55: 1856-1862, 1995.
38. Holmgren, L., O'Reilly, M., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-154, 1995.
39. Huang, A. Y., Bruce, A. T., Pardoll, D. M., and Levitsky, H. I. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med., 183: 769-776, 1996.
40. Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA, 93: 8578-8583, 1996.
41. Hornung, R. L., Longo, D. L., Bowersox, O. C., and Kwak, L. W. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor. J. Natl. Cancer Inst., 87: 1289-1296, 1995.
42. Kwak, L. W., Pennington, R., and Longo, D. L. Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype: a strategy for enhancing the specific antitumor effect of marrow grafts. Blood, 87: 3053-3060, 1996.